Scarica l'app Stockscreener
46.25
2.98%
-1.42
Dopo l'orario di chiusura:
46.25
Precedente Chiudi:
$47.67
Aprire:
$47.2
Volume 24 ore:
174.76K
Relative Volume:
0.53
Capitalizzazione di mercato:
$1.49B
Reddito:
-
Utile/perdita netta:
$-38.95M
Rapporto P/E:
-31.13
EPS:
-1.4857
Flusso di cassa netto:
$-50.43M
1 W Prestazione:
-2.67%
1M Prestazione:
+0.87%
6M Prestazione:
+92.55%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$45.50
$47.20
Intervallo di 1 settimana:
$45.50
$49.91
Portata 52W:
$13.36
$50.16
Lb Pharmaceuticals Inc Stock (LBRX) Company Profile
Nome
Lb Pharmaceuticals Inc
Settore
Industria
Telefono
917-450-6581
Indirizzo
575 MADISON AVENUE, NEW YORK
Compare LBRX vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LBRX
Lb Pharmaceuticals Inc
|
46.25 | 1.54B | 0 | -38.95M | -50.43M | -1.4857 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lb Pharmaceuticals Inc Stock (LBRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-27 | Iniziato | H.C. Wainwright | Buy |
| 2026-04-10 | Iniziato | Craig Hallum | Buy |
| 2026-01-09 | Iniziato | Roth Capital | Buy |
| 2025-10-06 | Iniziato | Leerink Partners | Outperform |
| 2025-10-06 | Iniziato | Piper Sandler | Overweight |
| 2025-10-06 | Iniziato | Stifel | Buy |
Mostra tutto
Lb Pharmaceuticals Inc Borsa (LBRX) Ultime notizie
Bank of America Corp DE Has $410,000 Stock Position in LB Pharmaceuticals Inc $LBRX - marketbeat.com
LB Pharmaceuticals Inc (LBRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bank of New York Mellon Corp Makes New $1.78 Million Investment in LB Pharmaceuticals Inc $LBRX - marketbeat.com
LB Pharmaceuticals (NASDAQ: LBRX) Names Joseph M. Miller as CFO with $530K Salary and 200,000-Share Stock Option - Kalkine Media
2 Reasons LB Pharmaceuticals (LBRX) Looks Pricey Following Its CFO Appointment - finance.yahoo.com
LB Pharmaceuticals to Participate in Upcoming September Investor Events - GlobeNewswire
LB Pharmaceuticals Names Joseph M. Miller as CFO, Details Compensation and Severance Package - Kalkine Media
LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 4.3%Here's What Happened - marketbeat.com
LB Pharmaceuticals (NASDAQ: LBRX) Appoints Joseph M. Miller as CFO with $530K Salary and Equity Incentives - Kalkine Media
LB Pharmaceuticals Inc Announces Appointment of Joseph M. Miller to Chief Financial Officer, Effective September 2, 2026 - marketscreener.com
LB Pharmaceuticals Appoints Joseph Miller as New CFO - TipRanks
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer - The Manila Times
LB Pharmaceuticals (LBRX) Edges Lower to $47.14 as Support HoldsShakeout Pattern - siam.in
LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
HC Wainwright Issues Pessimistic Forecast for LBRX Earnings - marketbeat.com
LB Pharmaceuticals (NASDAQ:LBRX) Sets New 52-Week High After Analyst Upgrade - marketbeat.com
H.C. Wainwright raises LB Pharmaceuticals price target to $60 By Investing.com - Investing.com India
HC Wainwright Forecasts Strong Price Appreciation for LB Pharmaceuticals (NASDAQ:LBRX) Stock - marketbeat.com
Great Lakes Advisors LLC Purchases Shares of 30,410 LB Pharmaceuticals Inc $LBRX - marketbeat.com
LB Pharmaceuticals (NASDAQ:LBRX) Sets New 12-Month HighTime to Buy? - MarketBeat
LB (LBRX) Technical Check: Climbs 1.88% to $47.10 on the Day; Level Position: the $44.74 to $49.46 Range Remains in FocusPositive Gamma - vinanet.vn
LB Pharmaceuticals (NASDAQ:LBRX) Cut to Sell at Wall Street Zen - marketbeat.com
LB Pharmaceuticals (LBRX) investor group reports 5.0% beneficial stake in 13G/A - Stock Titan
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook By Investing.com - Investing.com South Africa
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook - Investing.com
Stifel Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $53 - Moomoo
LB Pharmaceuticals (LBRX) Slips 2.45% as Key Support Levels Come into FocusStop Hunt - vinanet.vn
LB PHARMACEUTICALS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $55 FROM $40 - webull.com
LB Pharmaceuticals Inc Common Stock (NASDAQ: LBRX) Stock Price, News & Analysis - Kalkine
BMO Capital Markets Increases LB Pharmaceuticals (NASDAQ:LBRX) Price Target to $54.00 - MarketBeat
LBRX SWOT Analysis: Key Insights from 10-Q Filing - GuruFocus
Form 8K LB Pharmaceuticals Inc For: 11 August - Investing.com India
LB Pharmaceuticals Inc Stock 12‑Month Price Target Raised to $47.67, Implies 4% Upside - TradingView
LB Pharmaceuticals Submits Q2 2026 SEC Form 10-Q Reporting 32.26M Shares Outstanding - Kalkine Media
LB Pharmaceuticals2026 Funding Rounds & List of Investors - Tracxn
LB Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Form 8K LB Pharmaceuticals Inc For: 11 August By Investing.com - Investing.com Nigeria
LB Pharmaceuticals Q2 Loss Per Share Narrows - Yahoo Finance
LB PHARMACEUTICALS INC Q2 2026: Revenue $0 Net loss $(51.6M), EPS $(1.71) — 10-Q Summary - TradingView
Earnings Flash (LBRX) LB Pharmaceuticals Posts Q2 Loss $1.71 a Share, vs. FactSet Est of $0.81 Loss - marketscreener.com
LB Pharmaceuticals Reports Q2 2026 Results, Advances LB-102 Timeline and Pipeline Expansion - Quiver Quantitative
LB Pharmaceuticals reports Q2 2026 net loss of $51.6M, cash $327.8M; pivots LB-102 development - TradingView
LB Pharmaceuticals Q2 net loss widens on higher R&D costs - TradingView
LB Pharmaceuticals Inc.: Q2 Earnings Snapshot - The Daily Gazette
Press Release: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Moomoo
LB Pharmaceuticals (LBRX) Earnings Date and Reports 2026 $LBRX - marketbeat.com
LB Pharmaceuticals (NASDAQ:LBRX) Sets New 52-Week HighTime to Buy? - MarketBeat
Janus Henderson Group PLC Takes Position in LB Pharmaceuticals Inc $LBRX - MarketBeat
LBRX Q1 2026 Earnings: Narrower Loss of -$0.67 Beats Estimates, Yet Shares Slide 5.23% - vinanet.vn
LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
HC Wainwright Issues Optimistic Estimate for LBRX Earnings - MarketBeat
Lb Pharmaceuticals Inc Azioni (LBRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):